City Therapeutics Inc. , an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range. The company, which counts Arch...
10.16.2026 Bloomberg.com and 1 sites
SSR Mining disclosed a S-K 1300 Technical Report Summary for the Marigold Complex showing 3. 96 Moz total Mineral Reserves and an after-tax NPV(5%) of $3, 334 million. Key Highlights: Filed a 2026 Mar...
10.13.2026 Tradingview.com and 1 sites
The Business Research Company’s Analysis of Eyewear Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, October 12, 2026 / EINPresswire. com...
10.13.2026 Einpresswire.com and 47 sites
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that the U. S. Food and Drug Administration (FDA) has approved BRYTLY ® Redness Reliev...
10.16.2026 Centralcharts.com and 3 sites
City Therapeutics filed a final prospectus for its initial public offering on the Nasdaq Global Market under the ticker CTY. The company is offering 11, 111, 111 shares at $18. 00 per share, for gross proceeds of approximately $200 million, with an additional 1, 666, 666-share over-allotment option. Goldman Sachs, Jefferies, Stifel, and Oppenheimer are acting as underwriters, and the company qualifies as an emerging growth company. Business Description City Therapeutics is a clinical-stage biote...
10.16.2026 Tradingview.com
LAVAL, QC, Oct. 19, 2026 /CNW/ — Bausch Health, Canada Inc. , a subsidiary of Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), today announced expanded public reimbursement for PrOKEDI® (extended-...
10.19.2026 Newswire.ca and 16 sites
Arena Physica's Heaviside, the first foundation model for electromagnetism, brings AI-powered electromagnetic design to the RF, photonics, and semiconductor ecosystem on Microsoft Discovery NEW YORK ,...
10.13.2026 Prnewswire.com and 4 sitesAs filed with the Securities and Exchange Commission on October 13, 2026 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 _____________________ ...
10.13.2026 Au.advfn.com and 2 sites
Flanged intrascleral intraocular lens (IOL) fixation with the double-needle technique, first described by Yamane et al in 2017, ¹ has become a widely used option for secondary IOL placement in eyes wi...
10.15.2026 Ophthalmologytimes.com
A new month—and season—translates to changes … and we certainly have some updates in the eyecare leadership space to report. The biggest shake up: Bausch + Lomb Corporation has named a new interim CEO. Meanwhile, a few other companies have made their...
10.19.2026 Eyesoneyecare.com